13% of Parkinson's disease patients have genetic forms, suggesting expanded genetic testing for all patients.
A study in the medical journal Brain reveals a higher-than-expected prevalence of gene mutations in Parkinson's disease patients, with 13% found to have genetic forms of the disease. The rate was 18% in patients with known risk factors and over 9% in those without known risk factors. These findings suggest that genetic testing should be expanded for all Parkinson's patients, as gene-specific treatments are emerging, and genetic results could impact disease prognosis and reveal familial risks.
July 30, 2024
9 Articles